Annual Accounts Payable
$1.66 M
-$727.00 K-30.47%
31 December 2023
Summary:
VYNE Therapeutics annual accounts payable is currently $1.66 million, with the most recent change of -$727.00 thousand (-30.47%) on 31 December 2023. During the last 3 years, it has fallen by -$4.85 million (-74.52%). VYNE annual accounts payable is now -74.52% below its all-time high of $6.51 million, reached on 31 December 2021.VYNE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$3.99 M
-$530.00 K-11.74%
30 September 2024
Summary:
VYNE Therapeutics quarterly accounts payable is currently $3.99 million, with the most recent change of -$530.00 thousand (-11.74%) on 30 September 2024. Over the past year, it has increased by +$2.33 million (+140.27%). VYNE quarterly accounts payable is now -71.76% below its all-time high of $14.11 million, reached on 31 March 2020.VYNE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VYNE Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +140.3% |
| 3 y3 years | -74.5% | -38.8% |
| 5 y5 years | -56.0% | +5.7% |
VYNE Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.5% | at low | -38.8% | +456.7% |
| 5 y | 5 years | -74.5% | at low | -71.8% | +456.7% |
| alltime | all time | -74.5% | +160.4% | -71.8% | +456.7% |
VYNE Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.99 M(-11.7%) |
| June 2024 | - | $4.52 M(+61.6%) |
| Mar 2024 | - | $2.79 M(+68.5%) |
| Dec 2023 | $1.66 M(-30.5%) | $1.66 M(+131.7%) |
| Sept 2023 | - | $716.00 K(-38.2%) |
| June 2023 | - | $1.16 M(-47.7%) |
| Mar 2023 | - | $2.21 M(-7.2%) |
| Dec 2022 | $2.39 M(-63.3%) | $2.39 M(-5.4%) |
| Sept 2022 | - | $2.52 M(+76.3%) |
| June 2022 | - | $1.43 M(-60.4%) |
| Mar 2022 | - | $3.61 M(-44.5%) |
| Dec 2021 | $6.51 M(+36.2%) | $6.51 M(-14.6%) |
| Sept 2021 | - | $7.62 M(-24.4%) |
| June 2021 | - | $10.08 M(+188.8%) |
| Mar 2021 | - | $3.49 M(-27.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $4.78 M(+26.8%) | $4.78 M(+3.4%) |
| Sept 2020 | - | $4.62 M(-53.6%) |
| June 2020 | - | $9.95 M(-29.5%) |
| Mar 2020 | - | $14.11 M(+274.3%) |
| Dec 2019 | $3.77 M(+14.6%) | $3.77 M(+26.0%) |
| Sept 2019 | - | $2.99 M(-36.4%) |
| June 2019 | - | $4.70 M(+24.4%) |
| Mar 2019 | - | $3.78 M(+15.0%) |
| Dec 2018 | $3.29 M(+33.6%) | $3.29 M(+21.8%) |
| Sept 2018 | - | $2.70 M(-46.9%) |
| June 2018 | - | $5.09 M(+45.4%) |
| Mar 2018 | - | $3.50 M(+42.2%) |
| Dec 2017 | $2.46 M(+61.3%) | $2.46 M(-30.2%) |
| Sept 2017 | - | $3.53 M(+131.1%) |
| Dec 2016 | $1.53 M(+139.6%) | $1.53 M |
| Dec 2015 | $637.00 K | - |
FAQ
- What is VYNE Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly accounts payable year-on-year change?
What is VYNE Therapeutics annual accounts payable?
The current annual accounts payable of VYNE is $1.66 M
What is the all time high annual accounts payable for VYNE Therapeutics?
VYNE Therapeutics all-time high annual accounts payable is $6.51 M
What is VYNE Therapeutics quarterly accounts payable?
The current quarterly accounts payable of VYNE is $3.99 M
What is the all time high quarterly accounts payable for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly accounts payable is $14.11 M
What is VYNE Therapeutics quarterly accounts payable year-on-year change?
Over the past year, VYNE quarterly accounts payable has changed by +$2.33 M (+140.27%)